메뉴 건너뛰기




Volumn 7, Issue 45, 2016, Pages 74107-74119

Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice

Author keywords

Antitumor; Profilin; Toll like receptor; Toxoplasma gondii; Vaccine

Indexed keywords

AUTOLOGOUS WHOLE TUMOR CELL VACCINE; B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CXCL1 CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIGEL; MOLECULAR SCAFFOLD; MONOCYTE CHEMOTACTIC PROTEIN 5; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; RANTES; RECOMBINANT PROTEIN; TOXOPLASMA GONDII PROFILIN LIKE PROTEIN; TUMOR VACCINE; UNCLASSIFIED DRUG; CANCER VACCINE; PROFILIN;

EID: 84995785857     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12316     Document Type: Article
Times cited : (21)

References (44)
  • 7
    • 70350464351 scopus 로고    scopus 로고
    • Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
    • Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature immunology. 2009; 10:1178-1184.
    • (2009) Nature immunology , vol.10 , pp. 1178-1184
    • Murai, M.1    Turovskaya, O.2    Kim, G.3    Madan, R.4    Karp, C.L.5    Cheroutre, H.6    Kronenberg, M.7
  • 9
    • 77954679956 scopus 로고    scopus 로고
    • Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy
    • Krummen M, Balkow S, Shen L, Heinz S, Loquai C, Probst HC, Grabbe S. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. Journal of leukocyte biology. 2010; 88:189-199.
    • (2010) Journal of leukocyte biology , vol.88 , pp. 189-199
    • Krummen, M.1    Balkow, S.2    Shen, L.3    Heinz, S.4    Loquai, C.5    Probst, H.C.6    Grabbe, S.7
  • 10
    • 84971012251 scopus 로고    scopus 로고
    • Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses
    • Abdul-Cader MS, Amarasinghe A, Abdul-Careem MF. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Archives of virology. 2016.
    • (2016) Archives of virology
    • Abdul-Cader, M.S.1    Amarasinghe, A.2    Abdul-Careem, M.F.3
  • 14
    • 85019440984 scopus 로고    scopus 로고
    • Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
    • Toussi DN, Massari P. Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines (Basel). 2014; 2:323-353.
    • (2014) Vaccines (Basel) , vol.2 , pp. 323-353
    • Toussi, D.N.1    Massari, P.2
  • 15
    • 0037472447 scopus 로고    scopus 로고
    • Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically nontoxic double stranded RNA analogue poly [I]:poly [C(12) U] (Ampligen R)
    • Adams M, Navabi H, Jasani B, Man S, Fiander A, Evans AS, Donninger C, Mason M. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically nontoxic double stranded RNA analogue poly [I]:poly [C(12) U] (Ampligen R). Vaccine. 2003; 21:787-790.
    • (2003) Vaccine , vol.21 , pp. 787-790
    • Adams, M.1    Navabi, H.2    Jasani, B.3    Man, S.4    Fiander, A.5    Evans, A.S.6    Donninger, C.7    Mason, M.8
  • 16
    • 57349153494 scopus 로고    scopus 로고
    • A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
    • Butowski N, Chang SM, Junck L, DeAngelis LM, Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). J Neurooncol. 2009; 91:175-182.
    • (2009) J Neurooncol , vol.91 , pp. 175-182
    • Butowski, N.1    Chang, S.M.2    Junck, L.3    DeAngelis, L.M.4    Abrey, L.5    Fink, K.6    Cloughesy, T.7    Lamborn, K.R.8    Salazar, A.M.9    Prados, M.D.10
  • 18
    • 70349328115 scopus 로고    scopus 로고
    • TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination
    • Pulko V, Liu X, Krco CJ, Harris KJ, Frigola X, Kwon ED, Dong H. TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination. J Immunol. 2009; 183:3634-3641.
    • (2009) J Immunol , vol.183 , pp. 3634-3641
    • Pulko, V.1    Liu, X.2    Krco, C.J.3    Harris, K.J.4    Frigola, X.5    Kwon, E.D.6    Dong, H.7
  • 20
    • 55249083982 scopus 로고    scopus 로고
    • Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma
    • Hofmann MA, Kors C, Audring H, Walden P, Sterry W, Trefzer U. Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma. J Immunother. 2008; 31:520-527.
    • (2008) J Immunother , vol.31 , pp. 520-527
    • Hofmann, M.A.1    Kors, C.2    Audring, H.3    Walden, P.4    Sterry, W.5    Trefzer, U.6
  • 23
    • 18944395052 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe
    • Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia Diez A, Tebbs V, McRae S. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005; 152:939-947.
    • (2005) Br J Dermatol , vol.152 , pp. 939-947
    • Schulze, H.J.1    Cribier, B.2    Requena, L.3    Reifenberger, J.4    Ferrandiz, C.5    Garcia Diez, A.6    Tebbs, V.7    McRae, S.8
  • 24
    • 30644467155 scopus 로고    scopus 로고
    • Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma
    • Smorlesi A, Papalini F, Orlando F, Donnini A, Re F, Provinciali M. Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma. Gene Ther. 2005; 12:1324-1332.
    • (2005) Gene Ther , vol.12 , pp. 1324-1332
    • Smorlesi, A.1    Papalini, F.2    Orlando, F.3    Donnini, A.4    Re, F.5    Provinciali, M.6
  • 26
    • 79953759607 scopus 로고    scopus 로고
    • Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity
    • Jones RM, Sloane VM, Wu H, Luo L, Kumar A, Kumar MV, Gewirtz AT, Neish AS. Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut. 2011; 60:648-657.
    • (2011) Gut , vol.60 , pp. 648-657
    • Jones, R.M.1    Sloane, V.M.2    Wu, H.3    Luo, L.4    Kumar, A.5    Kumar, M.V.6    Gewirtz, A.T.7    Neish, A.S.8
  • 27
    • 84881558642 scopus 로고    scopus 로고
    • Flagellin enhances tumor-specific CD8(+) T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
    • Nguyen CT, Hong SH, Sin JI, Vu HV, Jeong K, Cho KO, Uematsu S, Akira S, Lee SE, Rhee JH. Flagellin enhances tumor-specific CD8(+) T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model. Vaccine. 2013; 31:3879-3887.
    • (2013) Vaccine , vol.31 , pp. 3879-3887
    • Nguyen, C.T.1    Hong, S.H.2    Sin, J.I.3    Vu, H.V.4    Jeong, K.5    Cho, K.O.6    Uematsu, S.7    Akira, S.8    Lee, S.E.9    Rhee, J.H.10
  • 28
    • 0027939611 scopus 로고
    • Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii
    • Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 1994; 153:2533-2543.
    • (1994) J Immunol , vol.153 , pp. 2533-2543
    • Gazzinelli, R.T.1    Wysocka, M.2    Hayashi, S.3    Denkers, E.Y.4    Hieny, S.5    Caspar, P.6    Trinchieri, G.7    Sher, A.8
  • 29
    • 77954439852 scopus 로고    scopus 로고
    • Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice
    • Pyo KH, Jung BK, Chai JY, Shin EH. Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice. Korean J Parasitol. 2010; 48:171-174.
    • (2010) Korean J Parasitol , vol.48 , pp. 171-174
    • Pyo, K.H.1    Jung, B.K.2    Chai, J.Y.3    Shin, E.H.4
  • 30
    • 84919778895 scopus 로고    scopus 로고
    • Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment
    • Pyo KH, Jung BK, Xin CF, Lee YW, Chai JY, Shin EH. Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment. Korean J Parasitol. 2014; 52:605-612.
    • (2014) Korean J Parasitol , vol.52 , pp. 605-612
    • Pyo, K.H.1    Jung, B.K.2    Xin, C.F.3    Lee, Y.W.4    Chai, J.Y.5    Shin, E.H.6
  • 32
  • 33
    • 84893115383 scopus 로고    scopus 로고
    • Innate immunity to Toxoplasma gondii infection
    • Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nature reviews Immunology. 2014; 14:109-121.
    • (2014) Nature reviews Immunology , vol.14 , pp. 109-121
    • Yarovinsky, F.1
  • 35
    • 77957942243 scopus 로고    scopus 로고
    • Anticancer properties of the IL-12 family-focus on colorectal cancer
    • Engel MA, Neurath MF. Anticancer properties of the IL-12 family-focus on colorectal cancer. Curr Med Chem. 2010; 17:3303-3308.
    • (2010) Curr Med Chem , vol.17 , pp. 3303-3308
    • Engel, M.A.1    Neurath, M.F.2
  • 36
    • 66449088641 scopus 로고    scopus 로고
    • Pathogen recognition and inflammatory signaling in innate immune defenses
    • Table of Contents
    • Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009; 22:240-273, Table of Contents.
    • (2009) Clin Microbiol Rev , vol.22 , pp. 240-273
    • Mogensen, T.H.1
  • 37
    • 79958812738 scopus 로고    scopus 로고
    • Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
    • Miyaji EN, Carvalho E, Oliveira ML, Raw I, Ho PL. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. Braz J Med Biol Res. 2011; 44:500-513.
    • (2011) Braz J Med Biol Res , vol.44 , pp. 500-513
    • Miyaji, E.N.1    Carvalho, E.2    Oliveira, M.L.3    Raw, I.4    Ho, P.L.5
  • 41
    • 0036486763 scopus 로고    scopus 로고
    • Role of chemokines in the biology of natural killer cells
    • Robertson MJ. Role of chemokines in the biology of natural killer cells. Journal of leukocyte biology. 2002; 71:173-183.
    • (2002) Journal of leukocyte biology , vol.71 , pp. 173-183
    • Robertson, M.J.1
  • 43
    • 0033826812 scopus 로고    scopus 로고
    • Interferon-gamma and interleukin-12 pathway defects and human disease
    • Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000; 11:321-333.
    • (2000) Cytokine Growth Factor Rev , vol.11 , pp. 321-333
    • Dorman, S.E.1    Holland, S.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.